High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland

被引：15

作者：

Chlabicz, S. ^{[1
]}

Flisiak, R. ^{[2
]}

Kowalczuk, O. ^{[3
]}

Wiercinska-Drapalo, A. ^{[2
]}

Pytel-Krolczuk, B. ^{[1
]}

Prokopowicz, D. ^{[2
]}

Chyczewski, L. ^{[3
]}

机构：

[1] Dept Family Med & Community Nursing, PL-15054 Bialystok, Poland

[2] Med Univ Bialystok, Dept Infect Dis, Bialystok, Poland

[3] Med Univ Bialystok, Dept Clin Mol Biol, Bialystok, Poland

来源：

JOURNAL OF MEDICAL VIROLOGY | 2008年 / 80卷 / 04期

关键词：

genotype; Hepacivirus; hepatitis C; intravenous; substance abuse;

D O I：

10.1002/jmv.21107

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The aim of this study was to describe the distribution of hepatitis C genotypes among intravenous drug users in north-eastern Poland. The study group included intravenous drug users recruited at a drug treatment center and a clinic for HIV-infected patients. HCV infection was confirmed by qualitative nested RT-PCR to test for the presence of HCV RNA. Genotypes were determined by 5'UTR sequencing and comparing the results with known genotype sequences. Among 111 HCV-infected and HCV-RNA-positive intravenous drug users, the most prevalent genotypes were 1 (38.7%), 3 (37.8%), and 4 (23.4%). Most infections with genotype 4 (88.5%) were found among HCV-HIV-coinfected drug users. The study demonstrated a high prevalence of genotype 4 (23.4%) among HCV-infected Polish drug users.

引用

页码：615 / 618

页数：4

共 50 条

[41] Hepatitis C Virus Subtypes Circulating Among Intravenous Drug Users in Lisbon, Portugal
Calado, Rita Almeida
Rocha, Maria Raquel
Parreira, Ricardo
Piedade, Joao
Venenno, Teresa
Esteves, Aida
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (04) : 608 - 615
[42] CD4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users
Anderson, Jeffrey P.
Horsburgh, C. Robert, Jr.
Williams, Paige L.
Tchetgen, Eric J. Tchetgen
Nunes, David
Cotton, Deborah
Seage, George R., III
OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (01):
[43] Search for hepatitis delta virus (HDV) infection in hepatitis C patients in north-eastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B
S. Chlabicz
A. Grzeszczuk
T.W. Łapiński
D. Prokopowicz
A. Panasiuk
European Journal of Epidemiology, 2003, 18 (6) : 559 - 561
[44] Prevalence of Hepatitis Delta Virus Infection among Hepatitis B Virus-Infected and Exposed Patients
Ramachandran, Krithiga
Agarwal, Reshu
Sharma, Manoj Kumar
Bhatia, Vikram
Gupta, Ekta
JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (04) : 197 - 201
[45] Management of hepatitis C virus infections in intravenous drug users
Robaeys, G
Matheï, C
Buntinx, F
Vanranst, M
ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 99 - 100
[46] Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India
Jat S.L.
Gupta N.
Kumar T.
Mishra S.
S A.
Yadav V.
Goel A.
Aggarwal R.
Indian Journal of Gastroenterology, 2015, 34 (2) : 164 - 168
[47] HEPATITIS-C VIRUS IN INTRAVENOUS-DRUG-USERS
BELL, J
BATEY, RG
FARRELL, GC
CREWE, EB
CUNNINGHAM, AL
BYTH, K
MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (05) : 274 - 276
[48] Treatment of hepatitis C virus infection in intravenous drug users
Cowan, Matthew L.
Maxwell, James D.
ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
[49] Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015
Rossetti, B.
Bai, F.
Tavelli, A.
Galli, M.
Antinori, A.
Castelli, F.
Pellizzer, G.
Cozzi-Lepri, A.
Bonora, S.
Monforte, A. d'Arminio
Puoti, M.
De Luca, A.
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (04) : 422 - 427
[50] Is the care of drug users infected with hepatitis C virus effective?
Lucidarme, D
Filoche, B
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (12): : 1077 - 1079

← 1 2 3 4 5 →